Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Chemical Name: (2R)-1-{4-[(2R
Basta-Kaim A
HeLa and HT-29 cells) treatment significantly increases the cytotoxicity of DNA damage
BMS 247615
InChi: InChI=1S/C40H30N10O6
Sunitinib Malate Size:Solid 2 mg Chemical Name: (2R)-1-{4-[(2RSunitinib, also known as SU11248, is the orally bioavailable malate salt of an indolinone based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet derived
US$ 117.50
US$ 28.94
US$ 1124.50
US$ 1071.00
US$ 49.00
US$ 80.00
US$ 20.00
US$ 76.00